RA

Reshma Arroon Gawalli

Active Director Director DIN 11019287
DIN 11019287 First appointment Apr 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Reshma Arroon Gawalli

Data last updated:

Reshma Arroon Gawalli is a Director at Indoventura Foodteck Private Limited (since 2025) and Director at Biovia Pharma Industries Private Limited (since 2025).

DIN 11019287
Primary Designation Director
First Appointment 18 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Indoventura Foodteck Private Limited U10790MH2025PTC446139
Director19 Apr 20252025Active
Director18 Apr 20252025Active

Board colleagues of Reshma Arroon Gawalli

Directorship timeline

Open interactive timeline →
Indoventura Foodteck Private Limited
Biovia Pharma Industries Private Limited
Premium access

Shareholding and investment profile for Reshma Arroon Gawalli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Reshma Arroon Gawalli

Reshma Arroon Gawalli currently holds 2 directorships: Indoventura Foodteck Private Limited (Director, since 19 Apr 2025); Biovia Pharma Industries Private Limited (Director, since 18 Apr 2025).

Reshma Arroon Gawalli was first appointed on 18 Apr 2025 as Director at Biovia Pharma Industries Private Limited.

The current boards of Reshma Arroon Gawalli's companies include Arroon Gawalli (Indoventura Foodteck Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available